T
Lehne’s Pharmacotherapeutics for Advanced Practice Nurses and
T T T T T T T
Physician Assistants
T
Laura D. Rosenthal, and Jacqueline Rosenjack Burchum
T T T T T T
2nd Edition
T
,Table of Contents
T T
Unit 01 Introduction
T T 1
Unit 02 Basic Principles of Pharmacology
T T T T T 6
Unit 03 Drug Therapy Across the Life Span
T T T T T T T 15
Unit 04 Peripheral Nervous System Drugs
T T T T T 22
Unit 05 Central Nervous System Drugs
T T T T T 31
Unit 06 Drugs for Pain
T T T T 38
Unit 07 Psychotherapeutic Drugs
T T T 43
Unit 08 Substance Use Disorders
T T T T 51
Unit 09 Drugs That Affect the Heart, Blood Vessels, Blood, and Blood Volume
T T T T T T T T T T T T 59
Unit 10 Drugs for Endocrine Disorders
T T T T T 68
Unit 11 Women’s Health
T T T 73
Unit 12 Men’s Health
T T T 78
Unit 13 Antiinflammatory, Antiallergic, and Immunologic Drugs
T T T T T T 83
Unit 14 Drugs for Bone and Joint Disorders
T T T T T T T 91
Unit 15 Respiratory Tract Drugs
T T T T 97
Unit 16 Gastrointestinal Drugs
T T T 102
Unit 17 Nutrition and Complimentary Therapies
T T T T T 110
Unit 18 Therapy of Infectious and Parasitic Diseases
T T T T T T T 116
Unit 19 Cancer Therapy
T T T 140
Unit 20 Drugs for Eyes, Ears, and Skin
T T T T T T T 145
Unit 21 Drugs Therapy in Acute Care
T T T T T T 152
,Test Bank - Lehne’s Pharmacotherapeutics for Advanced Practice Nurses & Physician Assistants, 2e (Rosenthal, 2021)
T T T T T T T T T T T T T T
Unit 01: Introduction
T T
Rosenthal: Lehne's Pharmacotherapeutics for Advanced Practice Nurses and Physician
T T T T T T T T T
Assistants, 2nd Edition
T T
MULTIPLE CHOICE T
1. A patient\ diagnosed\ with\ chronic\ pain\ calls\ to\ request\ an\ oxycodone\ (Oxycontin)\
T T T T T T T T T T T T
refill.\ Which\ action\ should\ the\ prescriber\ take\ initially?
T T T T T T T
a. Fax\ the\ renewal\ order\ to\ the\ pharmacy.
T T T T T T
b. Arrange\ to\ schedule\ an\ appointment\ with\ the\ patient. T T T T T T T
c. Verify\ the\ patient’s\ adherence\ to\ the\ prescribed\ drug\ regimen.
T T T T T T T T
d. Determine\ the\ patient’s\ current\ medication\ dosage\ and\ pain\ level. T T T T T T T T
ANS:\ B T
Schedule\ II\ medications\ are\ not\ eligible\ for\ refills,\ and\ prescriptions\ must\ be\ handwritten.\
T T T T T T T T T T T T T
It\ is\ important\ to\ verify\ the\ patient’s\ adherence\ to\ the\ drug\ regimen\ and\ determine\ the\
T T T T T T T T T T T T T T T
current\ dosage\ of\ medication\ and\ pain\ level;\ however,\ this\ can\ be\ accomplished\ by\
T T T T T T T T T T T T T
scheduling\ an\ appointment\ and\ evaluating\ the\ patient\ in\ person.
T T T T T T T T
2. A\ metered-dose\ albuterol\ inhaler\ is\ prescribed\ for\ asthma\ management.\ The\ patient\
T T T T T T T T T T T
reports\ feeling\ jittery\ sometimes\ when\ taking\ the\ medication,\ and\ does\ not\ feel\ that\ the\
T T T T T T T T T T T T T T
medication\ is\ always\ effective.\ Which\ action\ will\ the\ provider\ take\ to\ best\ minimize\
T T T T T T T T T T T T T
patient\ risks\ and\ maximize\ medication\ effectiveness?
T T T T T
a. Ask\ the\ patient\ to\ demonstrate\ use\ of\ the\ inhaler\ and\ assess\ effectiveness.
T T T T T T T T T T T
b. Assess\ the\ patient’s\ exposure\ to\ first-\ and\ second-hand\ tobacco\ smoke.
T T T T T T T T T
c. Auscultate\ the\ patient's\ l\un\W
g\ W
soWu.
ndTsBaS
ndMo.bW
taSin\ other\ relevant\ vital\ signs.
T T T T T T T T T T
d. Decrease\ the\ dosage\ to\ reduce\ side\ effects. T T T T T T
ANS:\ C T
Assessing\ and\ evaluating\ lung\ sounds\ as\ well\ as\ other\ vital\ signs\ helps\ determine\ the\
T T T T T T T T T T T T T T
patient's\ physical\ response\ to\ the\ medication\ and\ allows\ comparison\ to\ the\ patient's\
T T T T T T T T T T T T
baseline\ vital\ signs.\ Asking\ the\ patient\ to\ demonstrate\ inhaler\ use\ helps\ to\ evaluate\ the\
T T T T T T T T T T T T T T
patient’s\ ability\ to\ administer\ the\ medication\ properly\ and\ is\ part\ of\ an\ effective\
T T T T T T T T T T T T T
evaluation,\ but\ is\ not\ a\ priority\ intervention\ based\ on\ the\ patient’s\ current\ report.\
T T T T T T T T T T T T T
Assessing\ tobacco\ smoke\ exposure\ helps\ determine\ whether\ nondrug\ therapies,\ such\ as\
T T T T T T T T T T T
smoke\ avoidance,\ can\ be\ used\ as\ an\ adjunct\ to\ drug\ therapy,\ but\ does\ not\ relate\ to\ the\
T T T T T T T T T T T T T T T T T
patient’s\ current\ problem.\ Rewriting\ the\ prescription\ to\ decrease\ the\ dosage\ may\
T T T T T T T T T T T
address\ the\ degree\ of\ jitteriness\ experienced,
T T T T T
but\ does\ not\ address\ the\ patient’s\ concern\ that\ the\ drug\ is\ not\ always\ effective.
T T T T T T T T T T T T T
3. A\ patient\ is\ prescribed\ metronidazole\ for\ bacterial\ vaginosis.\ Which\ patient\ history\
T T T T T T T T T T T
finding\ would\ be\ most\ concerning\ to\ the\ provider?
T T T T T T T
a. The\ patient\ had\ a\ recent\ yeast\ infection.
T T T T T T
b. There\ is\ a\ family\ history\ of\ cervical\ cancer.
T T T T T T T
c. The\ patient\ drinks\ two\ glasses\ of\ wine\ every\ night.
T T T T T T T T
d. The\ patient\ is\ T T T
unemployed.\ ANS:\ C T T
1|Page T T T T T
, Test Bank - Lehne’s Pharmacotherapeutics for Advanced Practice Nurses & Physician Assistants, 2e (Rosenthal, 2021)
T T T T T T T T T T T T T T
Patients\ taking\ metronidazole\ should\ be\ educated\ not\ to\ drink\ alcohol\ to\ prevent\ a\
T T T T T T T T T T T T T
disulfiram-like\ reaction.\ It\ would\ be\ concerning\ that\ the\ patient\ drinks\ wine\ daily.\
T T T T T T T T T T T T
History\ of\ a\ yeast\ infection\ may\ indicate\ increased\ risk\ for\ recurrence\ with\
T T T T T T T T T T T T
administration\ of\ an\ antimicrobial.\ A\ family\ history\ of\ cervical\ cancer\ is\ not\ related\ to\
T T T T T T T T T T T T T T
administration\ of\ metronidazole.\ Unemployment\ can\ indicate\ lack\ of\ insurance\ coverage,\
T T T T T T T T T T
which\ may\ limit\ the\ patient’s\ ability\ to\ purchase\ medications;\ however,\ generic\
T T T T T T T T T T T
metronidazole\ is\ one\ of\ the\ less\ expensive\ medications. T T T T T T T
4. The\ provider\ prepares\ a\ patient\ with\ newly\ diagnosed\ type\ 1\ diabetes\ for\ hospital\
T T T T T T T T T T T T T
discharge.\ Which\ action\ by\ the\ provider\ will\ best\ support\ the\ patient’s\ ability\ to\
T T T T T T T T T T T T T
effectively\ manage\ medication\ therapy? T T T
a. Asking\ the\ patient\ to\ demonstrate\ how\ to\ measure\ and\ administer\ insulin
T T T T T T T T T T
b. Discussing\ methods\ of\ storing\ insulin\ and\ discarding\ syringes T T T T T T T
c. Giving\ information\ about\ how\ diet\ and\ exercise\ affect\ insulin\ requirements
T T T T T T T T T
d. Teaching\ the\ patient\ about\ the\ long-term\ consequences\ of\ poor\ diabetes\ control
T T T T T T T T T T
ANS:\ A T
Because\ insulin\ must\ be\ given\ correctly\ to\ control\ symptoms\ and\ prevent\ an\ overdose,\ it\
T T T T T T T T T T T T T T
is\ most\ important\ for\ the\ patient\ to\ know\ how\ to\ measure\ and\ administer\ it.\ Asking\ for\
T T T T T T T T T T T T T T T T
a\ demonstration\ of\ technique\ is\ the\ best\ way\ to\ determine\ whether\ the\ patient\ has\
T T T T T T T T T T T T T T
understood\ the\ teaching.\ The\ other\ teaching\ points\ are\ important\ as\ well,\ but\ they\ are\
T T T T T T T T T T T T T T
not\ as\ critical.
T T
5. A\ patient\ reports\ that\ a\ medication\ prescribed\ for\ recurrent\ migraine\ headaches\ is\
T T T T T T T T T T T T
not\ working.\ Which\ action\ is\ the\ prescriber’s\ priority\ when\ addressing\ the\ patient's\
T T T T T T T T T T T T
concern?
a. Ask\ the\ patient\ about\ the\ number\ and\ frequency\ of\ tablets\ taken.
T T T T T T T T T T
b. Assess\ the\ patient’s\ headache\ pain\ on\ a\ scale\ from\ 1\ to\ 10.
T T T T T T T T T T T
c. Prescribe\ a\ new\ medicationWfWorWm.iTgrBaiSnMe\ .
mW
TanSagement. T T T
d. Suggest\ biofeedback\ as\ an\ adjunct\ to\ drug\ therapy. T T T T T T T
ANS:\ A T
When\ evaluating\ the\ effectiveness\ of\ a\ drug,\ it\ is\ important\ to\ determine\ how\ often\ the\
T T T T T T T T T T T T T T T
patient\ is\ using\ the\ drug.\ Asking\ the\ patient\ to\ identify\ how\ many\ tablets\ are\ taken\ and\
T T T T T T T T T T T T T T T T
how\ often\ helps\ the\ provider\ determine\ effective\ dosages\ and\ adherence\ to\ the\
T T T T T T T T T T T T
medication\ regimen.\ The\ patient\ has\ already\ stated\ that\ the\ medication\ is\ not\ working;\
T T T T T T T T T T T T T
the\ actual\ level\ of\ pain\ may\ determine\ the\ degree\ to\ which\ it\ is\ not\ working,\ but\ it\
T T T T T T T T T T T T T T T T T
does\ not\ help\ the\ provider\ to\ determine\ why\ it\ is\ not\ working.\ The\ assessment\ process\
T T T T T T T T T T T T T T T
should\ gather\ as\ much\ information\ about\ compliance,\ symptoms,\ and\ drug\ effectiveness\
T T T T T T T T T T T
as\ possible\ before\ enacting\ a\ change\ in\ treatment.\ Biofeedback\ may\ be\ an\ effective\
T T T T T T T T T T T T T
adjunct\ to\ treatment,\ but\ it\ should\ not\ be\ recommended\ without\ complete\ information\
T T T T T T T T T T T T
about\ drug\ effectiveness.
T T
6. The\ drug\ manual\ states\ that\ older\ adult\ patients\ are\ at\ increased\ risk\ for\ hepatotoxicity.\
T T T T T T T T T T T T T T
Which\ action\ is\ most\ important\ when\ prescribing\ this\ medication\ to\ an\ 80-year-old\
T T T T T T T T T T T T
patient?
a. Obtaining\ baseline\ liver\ function\ studies T T T T
b. Ensuring\ that\ the\ drug\ is\ taken\ in\ the\ correct\ dose\ at\ the\ correct\ time
T T T T T T T T T T T T T
c. Discontinuing\ the\ order;\ the\ drug\ is\ contraindicated\ for\ this\ patient T T T T T T T T T
d. Giving\ the\ medication\ intravenously\ to\ avoid\ first\ pass\
T T T T T T T T
metabolism\ ANS:\ A T T
2|Page T T T T T